Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Identification and evaluation of the novel immunodominant antigen Rv2351c from Mycobacterium tuberculosis

Published:2017-01-01 Issue:1 Volume:6 Page:1-8
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Wang Xuezhi¹,Chen Shuangshuang¹²,Xu Yongjuan¹³,Zheng Huajun⁴,Xiao Tongyang¹,Li Yuqing¹⁵,Chen Xing¹⁵,Huang Mingxiang⁶,Zhang Haifeng⁷,Fang Xijing⁷,Jiang Yi¹,Li Machao¹,Liu Haican¹,Wan Kanglin¹

Affiliation:

1. State Key Laboratory for Infectious Diseases Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China

2. Central Laboratory, Beijing Research Institute for Tuberculosis Control, Beijing 100035, China

3. Prevention and Health Care, Huilongguan Community Health Service Center, Beijing 100096, China

4. Shanghai MOST Key Laboratory of Health and Disease Genomics, Chinese National Human Genome Center at Shanghai, Shanghai 201203, China

5. Epidemiology and Health Statistics, School of Public HealthUniversity of South China, Hengyang 421001, Hunan Province, China

6. Clinical Laboratory, Fuzhou Pulmonary Hospital, Fuzhou 350008, Fujian Province, China

7. Research and Development Department, Wuhan Institute of Biological Products Co., Ltd, Wuhan 430207, Hubei Province, China

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1038/emi.2017.34

Reference46 articles.

1. World Health Organization. Global Tuberculosis Report, 2016 Geneva: WHO.2016 Available at http://www.who.int/tb/publications/global_report/en/ (accessed 1 October 2016).

2. Immunity to Tuberculosis

3. Immunology of Tuberculosis

4. Systematic Review: T-Cell–based Assays for the Diagnosis of Latent Tuberculosis Infection: An Update

5. Superior T cell activation by ESAT-6 as compared with the ESAT-6–CFP-10 complex

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunoinformatics and structural aided approach to develop multi-epitope based subunit vaccine against Mycobacterium tuberculosis;Scientific Reports;2024-07-10

2. Immunogenicity and efficacy analyses of EPC002, ECA006, and EPCP009 protein subunit combinations as tuberculosis vaccine candidates;Vaccine;2023-06

3. A Multistage Antigen Complex Epera013 Promotes Efficient and Comprehensive Immune Responses in BALB/c Mice;Vaccines;2023-03-07

4. Long-Term Immunogenicity and In Vitro Prophylactic Protective Efficacy of M. tuberculosis Fusion Protein DR2 Combined with Liposomal Adjuvant DIMQ as a Boosting Vaccine for BCG;ACS Infectious Diseases;2023-02-21

5. Immunogenicity of Whole Mycobacterium intracellulare Proteins and Fingding on the Cross-Reactive Proteins between M. intracellulare and M. tuberculosis;BIOMED ENVIRON SCI;2021